Phase II Trial of Brostallicin and Cisplatin in Patients With Metastatic Triple Negative Breast Cancer
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 23 Mar 2017
At a glance
- Drugs Brostallicin (Primary) ; Cisplatin (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 13 Jun 2013 Final results presented at ASCO 2013.
- 26 Mar 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 10 Feb 2012 New source identified and integrated (Mayo Clinic).